Belden Inc.: Jefferies initiates coverage with hold rating; price target $114
BDC•Jefferies initiated coverage of Belden with a hold rating and a $114 price target.
Related News
Metagenomi Therapeutics CEO participates in Jefferies Global Healthcare Conference
MGX•
JBT Marel presents plan for about $150 million in FY 2028 cost synergies
JBTM•
BioAge Labs participates in three investor conferences
BIOA•
Sensata Technologies Holding plc: Jefferies initiates coverage with hold rating; price target $40
ST•
High Roller explores futures commission merchant operations to expand prediction markets platform
ROLR•